Still riding the high of last year’s twice-yearly HIV PrEP approval of lenacapavir as Yeztugo, Gilead Sciences is approaching ...
After a busy first day featuring headlines from a who's who of leading biopharma companies, the J.P. | The J.P. Morgan ...
The twisting journey of Pretzel Therapeutics’ top brass appears to have come full circle, with the biotech subsuming the very ...
Labcorp added to its suite of tests designed to detect cancer recurrence much earlier than traditional imaging.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback